Foster Dykema Cabot & Co. Inc. MA continued to hold its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,792 shares of the pharmacy operator’s stock at the close of the second quarter. Foster Dykema Cabot & Co. Inc. MA’s holdings in Walgreens Boots Alliance were worth $375,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in WBA. Waldron LP grew its holdings in Walgreens Boots Alliance by 67.7% during the first quarter. Waldron LP now owns 4,500 shares of the pharmacy operator’s stock valued at $373,000 after purchasing an additional 1,816 shares during the period. Cliftonlarsonallen Wealth Advisors LLC grew its holdings in Walgreens Boots Alliance by 5.3% during the first quarter. Cliftonlarsonallen Wealth Advisors LLC now owns 17,191 shares of the pharmacy operator’s stock valued at $1,428,000 after purchasing an additional 861 shares during the period. Great West Life Assurance Co. Can grew its holdings in Walgreens Boots Alliance by 0.9% during the first quarter. Great West Life Assurance Co. Can now owns 906,615 shares of the pharmacy operator’s stock valued at $75,257,000 after purchasing an additional 7,780 shares during the period. Usca Ria LLC grew its holdings in Walgreens Boots Alliance by 8.4% during the first quarter. Usca Ria LLC now owns 28,385 shares of the pharmacy operator’s stock valued at $2,357,000 after purchasing an additional 2,192 shares during the period. Finally, Commerzbank Aktiengesellschaft FI grew its holdings in Walgreens Boots Alliance by 42.0% during the first quarter. Commerzbank Aktiengesellschaft FI now owns 53,692 shares of the pharmacy operator’s stock valued at $4,459,000 after purchasing an additional 15,886 shares during the period. 60.16% of the stock is owned by institutional investors and hedge funds.

Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) opened at 73.20 on Monday. The firm’s 50-day moving average price is $80.00 and its 200-day moving average price is $81.15. Walgreens Boots Alliance, Inc. has a 52-week low of $72.77 and a 52-week high of $88.00. The stock has a market cap of $78.33 billion, a P/E ratio of 18.48 and a beta of 1.25.

Walgreens Boots Alliance declared that its board has approved a stock repurchase plan on Thursday, June 29th that authorizes the company to buyback $5.00 billion in shares. This buyback authorization authorizes the pharmacy operator to reacquire up to 5.9% of its shares through open market purchases. Shares buyback plans are generally a sign that the company’s leadership believes its shares are undervalued.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 12th. Shareholders of record on Friday, August 18th were issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 2.19%. The ex-dividend date was Wednesday, August 16th. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. Walgreens Boots Alliance’s dividend payout ratio is 40.30%.

Several brokerages have weighed in on WBA. Needham & Company LLC set a $94.00 price objective on Walgreens Boots Alliance and gave the company a “buy” rating in a report on Monday, July 17th. Pivotal Research set a $85.00 price target on Walgreens Boots Alliance and gave the stock a “hold” rating in a report on Sunday, July 2nd. Guggenheim reaffirmed a “buy” rating on shares of Walgreens Boots Alliance in a report on Monday, July 3rd. Raymond James Financial, Inc. reaffirmed a “market perform” rating on shares of Walgreens Boots Alliance in a report on Wednesday, September 27th. Finally, Morgan Stanley reaffirmed an “overweight” rating and issued a $95.00 price target on shares of Walgreens Boots Alliance in a report on Monday, July 3rd. One analyst has rated the stock with a sell rating, six have assigned a hold rating and fourteen have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $91.31.

ILLEGAL ACTIVITY WARNING: This report was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright legislation. The legal version of this report can be viewed at https://www.thecerbatgem.com/2017/10/09/foster-dykema-cabot-co-inc-ma-has-375000-holdings-in-walgreens-boots-alliance-inc-wba.html.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the stock in a transaction dated Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total transaction of $218,305.44. Following the completion of the transaction, the director now owns 19,151 shares of the company’s stock, valued at approximately $1,528,058.29. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 13.50% of the stock is owned by corporate insiders.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.